These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37011565)

  • 1. Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease.
    Risikesan J; Heebøll S; Kumarathas I; Funck KL; Søndergaard E; Johansen RF; Ringgaard S; Tolbod LP; Johannsen M; Kanstrup HL; Grønbæk H; Frystyk J; Gormsen LC; Nielsen S
    Atherosclerosis; 2023 May; 372():10-18. PubMed ID: 37011565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis.
    Risikesan J; Heebøll S; Kumarathas I; Søndergaard E; Johansen RF; Ringgaard S; Aagaard NK; Sandahl TD; Villadsen GE; Gormsen LC; Frystyk J; Jensen MD; Grønbæk H; Nielsen S
    J Lipid Res; 2024 Jul; 65(7):100580. PubMed ID: 38901559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men.
    Magkos F; Patterson BW; Mohammed BS; Mittendorfer B
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1568-74. PubMed ID: 17264219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).
    Heebøll S; Risikesan J; Ringgaard S; Kumarathas I; Sandahl TD; Grønbæk H; Søndergaard E; Nielsen S
    Diabetes; 2022 Nov; 71(11):2402-2411. PubMed ID: 36001750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approach using [
    Ustsinau U; Ehret V; Fürnsinn C; Scherer T; Helbich TH; Hacker M; Krššák M; Philippe C
    Clin Nutr; 2023 Oct; 42(10):1839-1848. PubMed ID: 37625314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic-associated fatty liver disease and lipoprotein metabolism.
    Heeren J; Scheja L
    Mol Metab; 2021 Aug; 50():101238. PubMed ID: 33892169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
    Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of very low-density lipoprotein triglyceride fatty acids to postabsorptive free fatty acid flux in obese humans.
    Bush NC; Triay JM; Gathaiya NW; Hames KC; Jensen MD
    Metabolism; 2014 Jan; 63(1):137-40. PubMed ID: 24140092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of exercise on plasma very low density lipoproteins (VLDL) and fatty acids.
    Børsheim E; Knardahl S; Høstmark AT
    Med Sci Sports Exerc; 1999 Apr; 31(4):522-30. PubMed ID: 10211846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation.
    Lin H; Wang L; Liu Z; Long K; Kong M; Ye D; Chen X; Wang K; Wu KK; Fan M; Song E; Wang C; Hoo RL; Hui X; Hallenborg P; Piao H; Xu A; Cheng KK
    Adv Sci (Weinh); 2022 Jul; 9(20):e2200742. PubMed ID: 35524581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten weeks of aerobic training does not result in persistent changes in VLDL triglyceride turnover or oxidation in healthy men.
    Nellemann B; Christensen B; Vissing K; Thams L; Sieljacks P; Larsen MS; Jørgensen JO; Nielsen S
    Eur J Endocrinol; 2014 Nov; 171(5):603-13. PubMed ID: 25117466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
    Heimberg M; Olubadewo JO; Wilcox HG
    Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of fatty acids at rest and during exercise: regulatory mechanisms.
    Jensen MD
    Acta Physiol Scand; 2003 Aug; 178(4):385-90. PubMed ID: 12864743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological interindividual variability in endogenous estradiol concentration does not influence adipose tissue and hepatic lipid kinetics in women.
    Magkos F; Fabbrini E; Patterson BW; Mittendorfer B; Klein S
    Eur J Endocrinol; 2022 Sep; 187(3):391-398. PubMed ID: 35895691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic free fatty acid disposal into very low-density lipoprotein triglycerides.
    Koutsari C; Mundi MS; Ali AH; Patterson BW; Jensen MD
    Diabetes; 2013 Jul; 62(7):2386-95. PubMed ID: 23434937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.
    Wang W; Basinger A; Neese RA; Shane B; Myong SA; Christiansen M; Hellerstein MK
    Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E540-7. PubMed ID: 11171611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged.
    Aarsland A; Chinkes D; Wolfe RR; Barrow RE; Nelson SO; Pierre E; Herndon DN
    Ann Surg; 1996 Jun; 223(6):777-87; discussion 787-9. PubMed ID: 8645051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.